Results 201 to 210 of about 57,167 (281)

Prevalence of cardiac dysfunction in men with erectile dysfunction: the EDcard study. [PDF]

BJU Int
Durukan E, Jensen CFS, Dons M, Sengeløv M, Landler NE, Skaarup KG, Højbjerg Lassen MC, Johansen ND, Østergren PB, Sønksen J, Fode M, Biering-Sørensen T.   +11 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Erectile Dysfunction Reversed After Adoption of a Whole Food Plant-Based Diet: A Case Report. [PDF]

Am J Lifestyle Med
Allen K, Jacob Y, Thein W, Esselstyn C, Ostfeld RJ.   +4 more
europepmc   +1 more source

New biosensors and transgenic mice for multiplex cGMP imaging

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a versatile second messenger that is important for human (patho‐)physiology and pharmacotherapy. Live‐cell imaging of cGMP with biosensors allows to elucidate its spatiotemporal dynamics in real time under close‐to‐native conditions. However, to monitor two separate cGMP pools or cGMP/cAMP
Markus Wolters, Martin Thunemann, Barbara Birk, Susanne Feil, Viacheslav O. Nikolaev, Moritz Lehners, Robert Feil   +6 more
wiley   +1 more source

Insomnia and Benzodiazepine Use as Risk Factors for Erectile Dysfunction: Clinical Evidence and In Silico Analysis of Physicochemical Properties. [PDF]

J Clin Med
Navarrete-Anaya V, Delgado-Enciso I, Hernández-Fuentes GA, Diaz-Martinez J, Delgado-Enciso OG, Sánchez-Arizmendi A, Figueroa-Gutiérrez A, Aguilar-Cota J, Venegas-Ramírez J, Calvo-Soto P, Carrazco-Peña KB, Fuentes-Murguia M, Ríos-Silva M, Guzmán-Esquivel J.   +13 more
europepmc   +1 more source

Injured external anal sphincter in erectile dysfunction

, 2001
A. Shafik
openalex   +1 more source

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, Sanika Mohagaonkar, Matti Walsdorff, Tanja Zeller, Filip Berisha, Viacheslav O. Nikolaev, Sergei D. Rybalkin   +8 more
wiley   +1 more source

Evaluation of Erectile Dysfunction as a Consequence of Urethroplasty: A Prospective Observational Study. [PDF]

Cureus
Mitra D, Bansal VK, Sharma D.
europepmc   +1 more source

INFLUENCE OF ERECTILE DYSFUNCTION ON DAILY LIFE AND GENERAL ATTITUDES TOWARDS TREATMENTS

, 2001
Masafumi Shirai, Yukie Takimoto, Nobuhisa Ishii, Teruaki Iwamoto   +3 more
openalex   +2 more sources

Is Verapamil Effective for Treating Patients With Chronic Rhinosinusitis With Nasal Polyps? A Systematic Review

Clinical Otolaryngology, EarlyView.
ABSTRACT Objective Identify and summarise the evidence on the efficacy of low‐dose verapamil use for adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Methods Two reviewers independently searched the data sources until the 28th of December 2023.
Fangxing Yin, Haris Ali, Alaa Abdelhalim, Hassan A. Elhassan   +3 more
wiley   +1 more source